This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Inthera, Inc.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Deog Young Choi: Innovator in Protein Expression Efficiency
Introduction
Deog Young Choi is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in enhancing the expression efficiency of target proteins. His innovative work has implications for the production of recombinant proteins, which are essential in various medical and industrial applications.
Latest Patents
Choi holds a patent for a novel peptide designed to enhance the expression efficiency of target proteins. The patent, titled "Peptide for enhancing expression efficiency of target protein, and fusion protein comprising same," describes a peptide or a partial sequence that not only improves expression efficiency but also enhances the solubility of the target protein. This dual functionality makes the peptide a valuable tool for producing recombinant proteins effectively.
Career Highlights
Choi is currently associated with Inthera, Inc., where he continues to advance his research in protein expression. His work is characterized by a commitment to innovation and practical applications in biotechnology. With a focus on enhancing protein production, Choi's contributions are paving the way for advancements in the field.
Collaborations
Choi collaborates with Baik Lin Seong, who is also involved in the research and development efforts at Inthera, Inc. Their partnership exemplifies the collaborative spirit in scientific research, driving forward the boundaries of knowledge and innovation.
Conclusion
Deog Young Choi's work in enhancing protein expression efficiency through innovative peptides represents a significant advancement in biotechnology. His contributions are crucial for the future of recombinant protein production, showcasing the importance of innovation in this field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile